FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387432960> ?p ?o ?g. }

• W4387432960 endingPage "308" @default.
• W4387432960 startingPage "298" @default.
• W4387432960 abstract "The most common and lethal consequence of chronic kidney disease (CKD) is atherosclerotic cardiovascular disease. The persistent inflammation present in CKD increases hepcidin levels. Iron accumulates in the arterial wall in atherosclerosis. Hepcidin-25 was thought to accelerate the development of atherosclerotic plaques by blocking iron release from macrophages. Therefore, we sought to determine the relationship between hepcidin-25 and asymptomatic atherosclerosis in non-dialysis CKD patients.Investigate the relationship between hepcidin-25 and subclinical atherosclerosis in non-dialysis CKD patients.Cross-sectional SETTINGS: Outpatient clinic for urology and nephrology at a university hospital SUBJECTS AND METHODS: Participants above the age of 18 years included a group of healthy controls and a group of CKD patients who were not routinely maintained on hemodialysis. The latter group was further divided according to eGFR into CKD-3, CKD-4 and CKD-5 subgroups. We excluded patients with comorbidities, patients with chronic liver disease, and other conditions or habits. CBC, kidney function tests, and serum levels of hepcidin-25 (SH-25), TNF-α, IL-6, high-sensitivity C-reactive protein (hs-CRP), TC, TG, LDL-C and HDL-C were assessed. To measure carotid intima media thickness (CIMT) and determine presence of plaques, carotid ultrasonography was performed. The near or far walls of common carotid artery, bulb, and internal carotid artery were used to measure CIMT.SH-25 association and indicators of subclinical atherosclerosis.128 participants, the control group (n=25) and the non-hemodialysis CKD patients (n=103) RESULTS: The CKD patients had significantly higher serum levels of markers of inflammation including IL-6, TNF-α, and hs-CRP (P<.001 for each) compared to the controls. There was a significantly higher level of TC, TG and LDL-C (P<.001 for each) and a lower level of HDL-C (P<.001) in the CDK patients compared to controls. SH-25 was considerably higher in all CKD subgroups, especially with progression of CKD. CIMT was increased in CKD patients especially CKD-4 and CKD-5 subgroups when compared to healthy participants (P<.001 for each). In the patient group, CIMT showed a positive correlation with SH-25, (r=.65 and P<.001), IL-6 (r=.65, P<.001), TNF-α (r=.71, P<.001), and hs-CRP (r=.52, P<.001). The ROC curve study showed that SH-25 (AUC=.86, P<.001), IL-6 (AUC=.83, P<.001), hs-CRP (AUC=.72, P<.001), TNF-α (AUC=.82, P<.001) were strong predictors of subclinical atherosclerosis in the CKD patients.SH-25 and CIMT had a positive relationship in CKD patients. The ROC curve showed that SH-25 is a reliable predictor of carotid atherosclerosis. Therefore, we suggest that SH-25 is a vital biomarker of asymptomatic atherosclerosis.Single-center." @default.
• W4387432960 created "2023-10-09" @default.
• W4387432960 creator A5012828452 @default.
• W4387432960 creator A5056152315 @default.
• W4387432960 creator A5062005330 @default.
• W4387432960 creator A5063064148 @default.
• W4387432960 creator A5068927812 @default.
• W4387432960 creator A5089090117 @default.
• W4387432960 date "2023-09-01" @default.
• W4387432960 modified "2023-10-17" @default.
• W4387432960 title "The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients" @default.
• W4387432960 cites W1149868669 @default.
• W4387432960 cites W1790020228 @default.
• W4387432960 cites W1846851754 @default.
• W4387432960 cites W1951800459 @default.
• W4387432960 cites W1976019480 @default.
• W4387432960 cites W1977387211 @default.
• W4387432960 cites W2029581633 @default.
• W4387432960 cites W2041497327 @default.
• W4387432960 cites W2044873909 @default.
• W4387432960 cites W2052538751 @default.
• W4387432960 cites W2056370317 @default.
• W4387432960 cites W2068629997 @default.
• W4387432960 cites W2074431458 @default.
• W4387432960 cites W2083187297 @default.
• W4387432960 cites W2098622034 @default.
• W4387432960 cites W2101415872 @default.
• W4387432960 cites W2121031602 @default.
• W4387432960 cites W2131471617 @default.
• W4387432960 cites W2150878988 @default.
• W4387432960 cites W2160966717 @default.
• W4387432960 cites W2163381055 @default.
• W4387432960 cites W2167794926 @default.
• W4387432960 cites W2198396599 @default.
• W4387432960 cites W2335533912 @default.
• W4387432960 cites W2565823552 @default.
• W4387432960 cites W2566013264 @default.
• W4387432960 cites W2586879243 @default.
• W4387432960 cites W2792122279 @default.
• W4387432960 cites W2810376815 @default.
• W4387432960 cites W2904214710 @default.
• W4387432960 cites W2910947255 @default.
• W4387432960 cites W2968468666 @default.
• W4387432960 cites W2969064380 @default.
• W4387432960 cites W2969880680 @default.
• W4387432960 cites W2995978302 @default.
• W4387432960 cites W3002868624 @default.
• W4387432960 cites W3045366154 @default.
• W4387432960 cites W3047188574 @default.
• W4387432960 cites W3176424922 @default.
• W4387432960 doi "https://doi.org/10.5144/0256-4947.2023.298" @default.
• W4387432960 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37805814" @default.
• W4387432960 hasPublicationYear "2023" @default.
• W4387432960 type Work @default.
• W4387432960 citedByCount "0" @default.
• W4387432960 crossrefType "journal-article" @default.
• W4387432960 hasAuthorship W4387432960A5012828452 @default.
• W4387432960 hasAuthorship W4387432960A5056152315 @default.
• W4387432960 hasAuthorship W4387432960A5062005330 @default.
• W4387432960 hasAuthorship W4387432960A5063064148 @default.
• W4387432960 hasAuthorship W4387432960A5068927812 @default.
• W4387432960 hasAuthorship W4387432960A5089090117 @default.
• W4387432960 hasBestOaLocation W43874329601 @default.
• W4387432960 hasConcept C113280763 @default.
• W4387432960 hasConcept C126322002 @default.
• W4387432960 hasConcept C159641895 @default.
• W4387432960 hasConcept C164705383 @default.
• W4387432960 hasConcept C2776761947 @default.
• W4387432960 hasConcept C2776768029 @default.
• W4387432960 hasConcept C2776914184 @default.
• W4387432960 hasConcept C2777910003 @default.
• W4387432960 hasConcept C2778063415 @default.
• W4387432960 hasConcept C2778653478 @default.
• W4387432960 hasConcept C2779339615 @default.
• W4387432960 hasConcept C2779978075 @default.
• W4387432960 hasConcept C2987047532 @default.
• W4387432960 hasConcept C3020110884 @default.
• W4387432960 hasConcept C54847362 @default.
• W4387432960 hasConcept C71924100 @default.
• W4387432960 hasConcept C90924648 @default.
• W4387432960 hasConceptScore W4387432960C113280763 @default.
• W4387432960 hasConceptScore W4387432960C126322002 @default.
• W4387432960 hasConceptScore W4387432960C159641895 @default.
• W4387432960 hasConceptScore W4387432960C164705383 @default.
• W4387432960 hasConceptScore W4387432960C2776761947 @default.
• W4387432960 hasConceptScore W4387432960C2776768029 @default.
• W4387432960 hasConceptScore W4387432960C2776914184 @default.
• W4387432960 hasConceptScore W4387432960C2777910003 @default.
• W4387432960 hasConceptScore W4387432960C2778063415 @default.
• W4387432960 hasConceptScore W4387432960C2778653478 @default.
• W4387432960 hasConceptScore W4387432960C2779339615 @default.
• W4387432960 hasConceptScore W4387432960C2779978075 @default.
• W4387432960 hasConceptScore W4387432960C2987047532 @default.
• W4387432960 hasConceptScore W4387432960C3020110884 @default.
• W4387432960 hasConceptScore W4387432960C54847362 @default.
• W4387432960 hasConceptScore W4387432960C71924100 @default.
• W4387432960 hasConceptScore W4387432960C90924648 @default.
• W4387432960 hasIssue "5" @default.

• next